I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.]最新文献_第4页

[Positron emission tomography with fluorodeoxyglucose in gastro-entero-pancreatic tumors: diagnostic role and prognostic implications]. [正电子发射断层扫描与氟脱氧葡萄糖在胃-肠-胰腺肿瘤:诊断作用和预后意义]。

I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.] Pub Date : 2005-05-01

C Pasquali, C Sperti, C Lunardi, S Scappin, F Chierichetti, G Liessi, S Pedrazzoli

{"title":"[Positron emission tomography with fluorodeoxyglucose in gastro-entero-pancreatic tumors: diagnostic role and prognostic implications].","authors":"C Pasquali, C Sperti, C Lunardi, S Scappin, F Chierichetti, G Liessi, S Pedrazzoli","doi":"","DOIUrl":"","url":null,"abstract":"From November 1994 to November 2004, seventy-seven patients with neuroendocrine gastro-entero-pancreatic tumor (71% pancreatic) were investigated with 18-fluorine-deoxi-glucose positron emission tomography (FDG-PET). PET results were compared with CT-scan, MRI and octreoscan scintigraphy and clinico-pathologic features of patients and survival. Overall PET sensitivity was 57%; 78% of malignant tumors, 67% of borderline and 17% of benign tumors were detected by FDG-PET. No duodenal tumor was detected by PET scan. Only 16% of primary less than 2 cm in size was localized. In 16% of cases PET scan provided new information able to change therapeutic management. In PET positive patients the addictive information obtained by PET scan when compared with octreoscan, MRI and CT scan were respectively 50% more, 26% more and 30% more. In malignant neuroendocrine tumors PET positivity was related to short survival. No patient with malignant tumor died for disease progression in the follow-up when PET was negative, while 13/35 PET positive patients died (p <0.003). FDG-PET proved to be a second line technique in neuroendocrine digestive tumors. PET results improve clinical staging of disease and is related to survival in malignant cases; in 16% of cases may change the therapeutic option.","PeriodicalId":84869,"journal":{"name":"I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.]","volume":"4 3","pages":"S68-71"},"PeriodicalIF":0.0,"publicationDate":"2005-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25821450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Xanthogranulomatous pyelonephritis and renal carcinoma. Report of a clinical case and review of the literature]. 黄色肉芽肿性肾盂肾炎和肾癌。【临床病例报告及文献复习】。

I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.] Pub Date : 2005-05-01

A Garberini, M Caricato, S Valeri, R Alloni, F Ausania, A Rosignoli, S Greco, C Rabitti, R Coppola

引用次数: 0

[Role of lymphadenectomy in the treatment of Merkel-cell tumors in i and ii stages]. [淋巴结切除术在i期和ii期默克尔细胞肿瘤治疗中的作用]。

I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.] Pub Date : 2005-05-01

M T Lonardo, U Marone, M G Chiofalo, R Cerra, S Mori, C Caracò, C Misso, A Germano, L Pezzullo

{"title":"[Role of lymphadenectomy in the treatment of Merkel-cell tumors in i and ii stages].","authors":"M T Lonardo, U Marone, M G Chiofalo, R Cerra, S Mori, C Caracò, C Misso, A Germano, L Pezzullo","doi":"","DOIUrl":"","url":null,"abstract":"Merkel cell carcinoma (MCC) is a rare, malignant skin cancer, exhibiting neuroendocrine differentiation, with a significant incidence of locoregional lymph nodal involvement (40%-73%). The accepted staging system classifies MCC as: stage I, localized skin disease; stage II, regional lymph node disease; stage III, metastatic disease. The clinical differentiation of stage I and II patients is difficult and understaging is frequent. Surgery, as first approach, represents the leading treatment for this neoplasm and, depending on stage consists in: local wide excision for stage I patients and local excision and lymphadenectomy for stage II. In our experience, lymphadenectomy, included in the initial treatment of all stage II patients, seemed to influence positively the prognosis. In comparing stage related recurrence and survival rates the results we obtained were better in stage II patients, where lymphadenectomy was included in the initial treatment than in stage I subjects, who received local excision alone as first treatment and lymphadenectomy as secondary treatment for nodal recurrence (overall recurrence rate 86% vs 20%, survival rate 71% vs 80% in stage I vs stage II patients). The performance of lymphadenectomy for stage I MCC could be reconsidered both for a more reliable staging of the disease and for a positive impact on recurrence and survival rates.","PeriodicalId":84869,"journal":{"name":"I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.]","volume":"4 3","pages":"S201-2"},"PeriodicalIF":0.0,"publicationDate":"2005-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25821251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Role of cutaneous thoraco-abdominal flap in the surgical treatment of advanced stage breast tumors]. 皮肤胸腹皮瓣在晚期乳腺肿瘤手术治疗中的作用

I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.] Pub Date : 2005-05-01

P Persichetti, B Cagli, S Tenna, L Fortunato, C E Vitelli

引用次数: 0

[Does incidence of sentinel lymph node metastasis increase after diagnostic manipulation in women with breast cancer?]. 乳腺癌患者前哨淋巴结转移的发生率是否在诊断操作后增加?

I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.] Pub Date : 2005-05-01

L Fortunato, M Farina, M Amini, L Costarelli, F R Piro, A Dell'Osso, F Scattoni, P Pompili, S Rapacchietta, C E Vitelli

引用次数: 0

[Total gastrectomy extended to the head of the pancreas and the liver with D4 lymphadenectomy for well-differentiated gastric carcinoma]. 【高分化胃癌行全胃切除至胰头、肝并行D4淋巴结切除术】。

I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.] Pub Date : 2005-05-01

I M Civello, C Nigro, D Matera, F Brandara, F Greco, G Brisinda

引用次数: 0

[Gastric hemangiopericytoma: unusual neoplasia but not always benign]. 胃血管外皮细胞瘤:不常见的肿瘤，但并不总是良性的。

I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.] Pub Date : 2005-05-01

L Montemurro, M Catarci, A Bellotti, R Piccirillo, B Battaglia, M A Viarengo, L Ricca, G B Grassi

引用次数: 0

[Ratio of lymph node metastasis in gastric carcinoma after D2 gastrectomy]. [D2胃切除术后胃癌淋巴结转移率]。

I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.] Pub Date : 2005-05-01

R Persiani, S Rausei, A Biondi, V Vigorita, G Retrosi, D D'Ugo

引用次数: 0

[Gastrointestinal stromal tumors: relationship between clinical factors and immediate results after resective surgery]. 【胃肠道间质瘤:临床因素与切除术后即刻效果的关系】。

I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.] Pub Date : 2005-05-01

A Antinori, P M C Tomaiuolo, R Ricci, P Giustacchini, A La Greca, F Pacelli, F Giuliante, C Coco

引用次数: 0

[Rectal cancer: locoregional recurrence in relation to surgical and complementary treatment]. [直肠癌:局部复发与手术及辅助治疗的关系]。

I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.] Pub Date : 2005-05-01

C R Asteria, R Valanzano, T Marcucci, F Tonelli

{"title":"[Rectal cancer: locoregional recurrence in relation to surgical and complementary treatment].","authors":"C R Asteria, R Valanzano, T Marcucci, F Tonelli","doi":"","DOIUrl":"","url":null,"abstract":"Much recent data have been published on the risk of local recurrence (LR) following curative surgery for rectal cancer and the impact of adjuvant therapy. On the other hand, improvements in surgical techniques, as the total mesorectal excision, have apparently reduced the risk of LR. Furthermore, in selected cases, neoadjuvant therapy seems to reduce much more the incidence of LR. A list of prognostic factors which affect the onset of LR, other than the different procedures, was considered. To investigate such evidences a retrospective analysis was undertaken in our series, focusing on examination of the employed techniques as potential predictors of local recurrence. Thus, in a 18-yr-period (1986-2003), two hundred and ninety-five patients who had undergone elective curative surgical resection of rectal cancer were included in the study. The demographic, operative and follow-up data were collected retrospectively. All patients underwent total mesorectal excision, whereas neoadjuvant therapy was performed in a selected series of patients, according to defined entry criteria patterns. Results evidenced LR in 7.1% of patients and occurred between 6 months to 8 year following surgery. Comparisons were made between patients who had different surgical procedures; indeed sphyncter saving procedures correlated with a higher incidence of LR rather than abdomino-perineal resection. Pelvic recurrences were observed more frequently compared to the anastomotic ones. A limited number of patients with LR underwent surgery due to the associated condition of metastatic lesions; the follow-up related to such series evidenced a mortality rate of 57% within 3 year from reoperation. A low local recurrence rate can be achieved after total mesorectal excision (TME) without preoperative radiotherapy. Our results suggest that preoperative radiotherapy may be employed only for those patients who are at a higher risk for local recurrence.","PeriodicalId":84869,"journal":{"name":"I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.]","volume":"4 3","pages":"S5-6"},"PeriodicalIF":0.0,"publicationDate":"2005-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25822380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0